BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20381084)

  • 1. Primary thoracic cavity gastrointestinal stromal tumor.
    Cheng JW; Lu SH; Xu ST; Wang H; Hou YY; Zheng RH; Tan YS
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):e29-31. PubMed ID: 20381084
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
    Turner J; Batus M; Leslie W; Coogan C; Saclarides TJ
    Am Surg; 2010 Aug; 76(8):E110-2. PubMed ID: 21513625
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
    El Hajj II; Chehal A; El Saghir NS
    Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastrointestinal stromal tumor (GIST): pathology in continuous development. Diagnostic-therapeutic strategies].
    Sianesi M
    Ann Ital Chir; 2009; 80(4):257-60. PubMed ID: 19967882
    [No Abstract]   [Full Text] [Related]  

  • 5. Education and imaging. Gastrointestinal: Sister Mary Joseph nodule.
    Lin CC; Liu KL; Lin JT; Lin MT; Wang HP
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1462. PubMed ID: 18854004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical analysis of 79 gastrointestinal tract stromal tumor cases].
    Liu ZM; Liang J; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):552-3. PubMed ID: 22093639
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic myeloid leukemia and gastrointestinal stromal tumor: simultaneous presentation.
    Gollard R; Wierda W; Trent J
    J Clin Oncol; 2007 Oct; 25(29):4682-3. PubMed ID: 17925564
    [No Abstract]   [Full Text] [Related]  

  • 8. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
    Hohenberger P
    Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of huge GIST of the stomach successfully resected following effective neoadjuvant chemotherapy.
    Tanaka N; Saka M
    Jpn J Clin Oncol; 2008 Nov; 38(11):790. PubMed ID: 18952707
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
    Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of positron emission and computed tomography scan in early evaluation of treatment response in gastrointestinal stromal tumor.
    Nozaki Y; Yanase M; Masaki N
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):A22. PubMed ID: 19362609
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors?
    Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS
    Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196
    [No Abstract]   [Full Text] [Related]  

  • 13. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
    Demetri G; DeMatteo RP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
    Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
    Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
    Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
    Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor rupture exposes the patient to an increased risk of relapse, regardless of the size and number of mitoses.
    Quintero CB; Cubedo R
    Anticancer Drugs; 2012 Jun; 23 Suppl():S1-2. PubMed ID: 22739664
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
    Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
    J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib in gastrointestinal stromal tumors.
    Bakshi CA; Jain RA; Sastry PS; Sainani AR; Advani SH
    J Assoc Physicians India; 2004 May; 52():403-9. PubMed ID: 15656032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expert consensus on surgical treatment for gastrointestinal stromal tumors].
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):947-8. PubMed ID: 18478940
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
    Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.